Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04ORP
|
|||
| Former ID |
DIB007026
|
|||
| Drug Name |
GMK
|
|||
| Synonyms |
(3-Deoxy-3-(3-Methoxy-Benzamido)-B-D-Galactopyranosyl)-(3-Deoxy-3-(3-Methoxy-Benzamido)-2-O-Sulfo-B-D-Galactopyranosyl)-Sulfide; 3-deoxy-3-[(3-methoxybenzoyl)amino]-beta-D-galactopyranosyl 3-deoxy-3-[(3-methoxybenzoyl)amino]-2-O-sulfo-1-thio-beta-D-galactopyranoside
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 3 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H36N2O15S2
|
|||
| Canonical SMILES |
COC1=CC=CC(=C1)C(=O)NC2C(C(OC(C2O)SC3C(C(C(C(O3)CO)O)NC(=O)C4=CC(=CC=C4)OC)OS(=O)(=O)O)CO)O
|
|||
| InChI |
1S/C28H36N2O15S2/c1-41-15-7-3-5-13(9-15)25(36)29-19-21(33)17(11-31)43-27(23(19)35)46-28-24(45-47(38,39)40)20(22(34)18(12-32)44-28)30-26(37)14-6-4-8-16(10-14)42-2/h3-10,17-24,27-28,31-35H,11-12H2,1-2H3,(H,29,36)(H,30,37)(H,38,39,40)/t17-,18-,19+,20+,21+,22+,23-,24-,27+,28+/m1/s1
|
|||
| InChIKey |
CNUFQRWWCPUUQG-CWKIZLMASA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | GMK (Progenics Pharmaceuticals). Curr Opin Investig Drugs. 2002 Jan;3(1):159-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.